Swedish Dignitana has announced that their medical device, the DigniCap scalp cooling system, will be offered at Piedmont Cancer Institute in Georgia.
FDA-cleared in 2015, the DigniCap Scalp Cooling System will be available this summer at Piedmont’s center in Atlanta, with installation at other Piedmont locations to follow.
The device features a patented tight-fitting silicone cooling cap that is placed directly on the head, and an outer neoprene cap that insulates and secures the silicone cap. The cooling cap is connected to a cooling and control unit with touch screen prompts. A liquid coolant circulates throughout the silicone cap, delivering consistent and controlled cooling to all areas of the scalp. The cap is fitted to the head, and the temperature of the scalp is lowered, resulting in vasoconstriction with reduced delivery of chemotherapy to the scalp, as well as reduced cellular uptake of drugs due to decreased intra follicular metabolic rate. These factors together reduce the risk of chemotherapy-induced hair loss.
DigniCap is now available in 21 states across the US. With the addition of the Piedmont Cancer Institute locations in Georgia, along with East Jefferson General Hospital in Louisiana and Mile High Oncology in Colorado there are now 77 partner sites currently contracted in the United States.